Sparrow MP - Search Results

1

Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.

Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB. Sparrow MP, et al. Clin Gastroenterol Hepatol. 2007 Feb;5(2):209-14. doi: 10.1016/j.cgh.2006.11.020. Clin Gastroenterol Hepatol. 2007. PMID: 17296529

2

COLAL-PRED Alizyme.

Hanauer SB, Sparrow M. Hanauer SB, et al. Curr Opin Investig Drugs. 2004 Nov;5(11):1192-7. Curr Opin Investig Drugs. 2004. PMID: 15573870 Review.

3

Therapy of ulcerative colitis.

Hanauer SB, Sparrow M. Hanauer SB, et al. Curr Opin Gastroenterol. 2004 Jul;20(4):345-50. doi: 10.1097/00001574-200407000-00008. Curr Opin Gastroenterol. 2004. PMID: 15703663

4

Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.

Sparrow MP, Hande SA, Friedman S, Lim WC, Reddy SI, Cao D, Hanauer SB. Sparrow MP, et al. Aliment Pharmacol Ther. 2005 Sep 1;22(5):441-6. doi: 10.1111/j.1365-2036.2005.02583.x. Aliment Pharmacol Ther. 2005. PMID: 16128682 Free article.

5

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.

Leong RW, Gearry RB, Sparrow MP. Leong RW, et al. Among authors: sparrow mp. Expert Opin Drug Saf. 2008 Sep;7(5):607-16. doi: 10.1517/14740338.7.5.607. Expert Opin Drug Saf. 2008. PMID: 18759713 Review.

6

Optimizing conventional therapies for inflammatory bowel disease.

Sparrow MP, Irving PM, Hanauer SB. Sparrow MP, et al. Curr Gastroenterol Rep. 2009 Dec;11(6):496-503. doi: 10.1007/s11894-009-0075-6. Curr Gastroenterol Rep. 2009. PMID: 19903426 Review.

7

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.

Haines ML, Ajlouni Y, Irving PM, Sparrow MP, Rose R, Gearry RB, Gibson PR. Haines ML, et al. Among authors: sparrow mp. Inflamm Bowel Dis. 2011 Jun;17(6):1301-7. doi: 10.1002/ibd.21458. Epub 2010 Sep 1. Inflamm Bowel Dis. 2011. PMID: 20812329

8

Optimizing thiopurine therapy in inflammatory bowel disease.

Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Chevaux JB, et al. Among authors: sparrow mp. Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14. Inflamm Bowel Dis. 2011. PMID: 20949566 Review.

9

Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.

Leung Y, Sparrow MP, Schwartz M, Hanauer SB. Leung Y, et al. Among authors: sparrow mp. J Crohns Colitis. 2009 Sep;3(3):162-7. doi: 10.1016/j.crohns.2009.02.003. Epub 2009 Mar 17. J Crohns Colitis. 2009. PMID: 21172265

10

Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease.

Sparrow MP. Sparrow MP. Gastroenterol Hepatol (N Y). 2008 Jul;4(7):505-11. Gastroenterol Hepatol (N Y). 2008. PMID: 21960930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page